Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-08 08:39 am Unchanged | 2024-12-31 | 13G | Seer, Inc. SEER | Schindel Yair Chaim | 4,923,196 8.350% | 0 (Unchanged) | Filing History |
| 2024-11-04 07:39 am Purchase | 2024-09-30 | 13G | Akoya Biosciences, Inc. AKYA | Schindel Yair Chaim | 4,878,459 9.860% | 1,801,264 (+58.54%) | Filing History |
| 2024-11-04 07:19 am Sale | 2024-09-30 | 13G | Sera Prognostics, Inc. SERA | Schindel Yair Chaim | 1,911,332 5.730% | -1,067,179 (-35.83%) | Filing History |
| 2024-02-12 08:27 am Unchanged | 2023-12-31 | 13G | Advaxis, Inc. ADXS | Schindel Yair Chaim | 560,602 1.310% | 0 (Unchanged) | Filing History |
| 2024-01-03 08:52 am Unchanged | 2023-12-31 | 13G | Seer, Inc. SEER | Schindel Yair Chaim | 4,923,196 7.710% | 0 (Unchanged) | Filing History |
| 2024-01-03 08:50 am Purchase | 2023-12-31 | 13G | Akoya Biosciences, Inc. AKYA | Schindel Yair Chaim | 3,077,195 6.270% | 158,756 (+5.44%) | Filing History |
| 2024-01-03 08:50 am Purchase | 2023-12-31 | 13G | Sera Prognostics, Inc. SERA | Schindel Yair Chaim | 2,978,511 9.500% | 1,060,000 (+55.25%) | Filing History |
| 2023-10-23 06:45 am Unchanged | 2023-10-18 | 13G | Advaxis, Inc. ADXS | Schindel Yair Chaim | 560,602 5.210% | 0 (Unchanged) | Filing History |
| 2023-06-13 07:18 am Purchase | 2023-06-12 | 13G | Akoya Biosciences, Inc. AKYA | Schindel Yair Chaim | 2,918,439 6.030% | 2,918,439 (New Position) | Filing History |
| 2023-05-18 11:23 am Purchase | 2023-05-17 | 13D | SOPHiA GENETICS SA SOPH | Schindel Yair Chaim | 4,933,205 7.680% | 1,722,338 (+53.64%) | Filing History |
| 2023-01-30 06:01 am Purchase | 2023-01-19 | 13G | Advaxis, Inc. ADXS | Schindel Yair Chaim | 560,602 12.200% | 560,602 (New Position) | Filing History |
| 2023-01-23 4:29 pm Sale | 2023-01-19 | 13G | Ayala Pharmaceuticals, Inc. AYLA | Schindel Yair Chaim | 0 0.000% | -2,991,473 (Position Closed) | Filing History |
| 2023-01-10 5:21 pm Unchanged | 2022-06-08 | 13D | Viracta Therapeutics, Inc. VIRX | Schindel Yair Chaim | 7,392,237 19.350% | 0 (Unchanged) | Filing History |
| 2023-01-10 4:35 pm Unchanged | 2022-06-08 | 13D | Viracta Therapeutics, Inc. VIRX | Schindel Yair Chaim | 7,392,237 19.350% | 0 (Unchanged) | Filing History |
| 2023-01-10 4:30 pm Purchase | 2023-01-09 | 13D | SOPHiA GENETICS SA SOPH | Schindel Yair Chaim | 3,210,867 5.000% | 3,210,867 (New Position) | Filing History |
| 2023-01-09 06:51 am Unchanged | 2022-12-31 | 13G | Ayala Pharmaceuticals, Inc. AYLA | Schindel Yair Chaim | 2,991,473 20.180% | 0 (Unchanged) | Filing History |
| 2023-01-09 06:47 am Unchanged | 2022-12-31 | 13G | Sera Prognostics, Inc. SERA | Schindel Yair Chaim | 1,918,511 6.190% | 0 (Unchanged) | Filing History |
| 2023-01-09 06:43 am Unchanged | 2022-12-31 | 13G | Seer, Inc. SEER | Schindel Yair Chaim | 4,923,196 7.860% | 0 (Unchanged) | Filing History |
| 2022-01-24 06:12 am Purchase | 2021-12-31 | 13G | Sera Prognostics, Inc. SERA | Schindel Yair Chaim | 1,918,511 6.200% | 1,918,511 (New Position) | Filing History |
| 2022-01-24 06:10 am Unchanged | 2021-12-31 | 13G | Ayala Pharmaceuticals, Inc. AYLA | Schindel Yair Chaim | 2,991,473 21.470% | 0 (Unchanged) | Filing History |